Latest filing published 05 May 2021 for Black Diamond Therapeutics, Inc., €55k.
Filing timeline
BuySaleInsider track record
Christopher D. Roberts: trading record in brief
Christopher D. Roberts (senior executive) discloses dealings in Black Diamond Therapeutics, Inc. to SEC (Form 4). In total, 25 filings cover trades dated from 3 September 2020 to 3 May 2021.
The open-market record consists of 14 sales worth €692k, with no purchase. Outside the open market, there are 11 option exercises. Since January 2021: no purchases and 7 sales on the market.
The latest filing, published on 5 May 2021, reports an open-market sale of €55k in Black Diamond Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher D. Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$26.645.7% of flowCommon StockSEC:0000899243-21-018358:1
- 2,500 shares@ US$10.86100.0% of flowCommon StockSEC:0000899243-21-018358:0
- 2,500 shares@ US$10.862.4% of flowCommon StockSEC:0000899243-21-015309:0
- 2,500 shares@ US$25.545.6% of flowCommon StockSEC:0000899243-21-015309:1
- 2,500 shares@ US$10.862.7% of flowCommon StockSEC:0000899243-21-009904:0
- 1,616 shares@ US$25.854.1% of flowCommon StockSEC:0000899243-21-009904:1
- 884 shares@ US$26.572.3% of flowCommon StockSEC:0000899243-21-009904:2
- 2,500 shares@ US$10.862.3% of flowCommon StockSEC:0000899243-21-004959:0
- 2,500 shares@ US$25.355.4% of flowCommon StockSEC:0000899243-21-004959:1
- 2,500 shares@ US$10.862.3% of flowCommon StockSEC:0000899243-21-000743:0
- 1,963 shares@ US$31.315.2% of flowCommon StockSEC:0000899243-21-000743:1
- 537 shares@ US$31.781.4% of flowCommon StockSEC:0000899243-21-000743:2
- 3,200 shares@ US$10.864.8% of flowCommon StockSEC:0000899243-20-034189:0
- 2,500 shares@ US$10.863.7% of flowCommon StockSEC:0000899243-20-032759:0
- 2,500 shares@ US$32.422111.1% of flowCommon StockSEC:0000899243-20-032759:1
- 5,000 shares@ US$10.867.6% of flowCommon StockSEC:0000899243-20-030997:0
- 5,000 shares@ US$34.9024.6% of flowCommon StockSEC:0000899243-20-030997:1
- 2,500 shares@ US$10.863.9% of flowCommon StockSEC:0000899243-20-030419:0
- 2,500 shares@ US$31.949211.4% of flowCommon StockSEC:0000899243-20-030419:1
- 2,500 shares@ US$10.863.8% of flowCommon StockSEC:0000899243-20-027717:0
- 2,273 shares@ US$31.204210.0% of flowCommon StockSEC:0000899243-20-027717:1
- 227 shares@ US$31.9851.0% of flowCommon StockSEC:0000899243-20-027717:2
- 2,500 shares@ US$10.863.8% of flowCommon StockSEC:0000899243-20-024374:0
- 142 shares@ US$28.950.6% of flowCommon StockSEC:0000899243-20-024374:1
- 2,358 shares@ US$29.639.8% of flowCommon StockSEC:0000899243-20-024374:2
25 of 25 declarations
